Treating CML: What Happens if a TKI Stops Working

If a TKI is not effective against CML, there are a number of other treatments your healthcare providers may recommend.

A blister pack containing TKI oral medication. TKIs are the standard in treatment for CML.

Tyrosine kinase inhibitors (TKIs) are the preferred treatment for chronic myeloid leukemia (CML). TKIs are a type of targeted therapy, and work by targeting a gene called BCR-ABL, which is found in CML cells, but not found in normal healthy cells. TKIs are an effective treatment for many people with CML.

However, sometimes CML does not respond to treatment with a TKI drug. Other times, a TKI drug may cause unwelcome side effects that seriously impact a person’s quality of life or put their health at risk.

Here, we look at the next steps in treatment when a TKI isn’t working.

A higher dose or a different TKI

When a TKI drug isn’t effective against CML or causes unmanageable side effects, a healthcare team may recommend switching to a higher dose or a different TKI drug. There are a number of different TKI drugs available that are used to treat CML. Depending on the genetic changes found in the leukemia cells, different drugs might have a better chance of success.


Before TKIs, immunotherapy drugs were the preferred treatment for CML. This approach is still used in certain cases, such as when CML becomes resistant to treatment with TKIs. Studies are also investigating therapy regimens that combine TKI and immunotherapy. Immunotherapy drugs do not target cancer cells directly, but instead help the body’s immune system kill cancer cells.


There are several chemotherapy drugs that are approved for the treatment of CML, which are used in certain cases. Chemotherapy drugs contain powerful chemicals that kill cancer cells. These drugs also have several other applications in treating CML—they may be used to lower a white blood cell count that is very high, may be used to shrink an enlarged spleen, and are a component of stem cell transplant therapy.

Stem cell transplant

This approach begins with high doses of chemotherapy, sometimes combined with radiation therapy. High doses of these therapies will kill off CML cells, but will also badly damage the bone marrow. In order to repair the bone marrow, the body will require a stem cell transplant. This transplant may come from a donor (this is called an allogeneic transplant) or from a supply of the patient’s stem cells that are collected before chemotherapy and radiation therapy (this is called an autologous transplant). Allogenic transplants are more commonly used because autologous transplants carry a risk of transplanting leukemia cells along with healthy stem cells.

The decision to use this treatment will depend on a number of factors, including the phase of the CML, previous therapies for CML, whether the person with CML is strong enough to undergo this therapy, and if a donor is available.

Clinical trials

People with advanced CML may want to consider participating in a clinical trial. Medical researchers are continually developing new treatments for cancer. Participating in a clinical trial may offer access to leukemia therapies and regimens that are not yet available to the public.

Article sources open article sources

American Cancer Society. "Treating Chronic Myeloid Leukemia by Phase."
UpToDate. "Patient education: Chronic myeloid leukemia (CML) in adults (Beyond the Basics)."
Leukemia & Lymphoma Society. "Tyrosine Kinase Inhibitor (TKI) Therapy."
NCI Dictionary. "BCR-ABL fusion gene."
National Cancer Institute. "Targeted Therapies for Chronic Myeloid Leukemia."
Maher Chaar, Jeff Kamta and Sihem Ait-Oudhia. "Mechanisms, monitoring, and management of tyrosine kinase inhibitors–associated cardiovascular toxicities." OncoTargets and Therapy, 2018. Vol. 11.
Jorge Cortes and Hagop Kantarjian. "Chronic myeloid leukemia: sequencing of TKI therapies." Hematology: American Society of Hematology Education Program, 2016. Vol. 1.
Shady Adnan Awad, Matti Kankainen, et al. "Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia." Blood Advances, 2020. Vol. 4, No. 3.
Puligundla Krishna Chaitanya, Karnam Ashok Kumar, Bala Stalin, Gundeti Sadashivudu, and Maddali Lakshmi Srinivas. "The Role of Mutation Testing in Patients with Chronic Myeloid Leukemia in Chronic Phase after Imatinib Failure and Their Outcomes after Treatment Modification: Single-institutional Experience Over 13 Years." Indian Journal of Medical and Pediatric Oncology, 2017. Vol. 38, No. 3.
American Cancer Society. "Interferon Therapy for Chronic Myeloid Leukemia."
Vaclava Polivkova, Peter Rohon, et al. "Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients." PLOS ONE, 2016.
Peter E. Westerweel, Peter A. W. te Boekhorst, Mark-David Levin and Jan J. Cornelissen. "New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia." Frontiers in Oncology, 2019. Vol. 6.
American Cancer Society. "Chemotherapy for Chronic Myeloid Leukemia."
University of Rochester Medical Center. "Chronic Myeloid Leukemia (CML): Chemotherapy."
Cancer.Net. "Leukemia - Chronic Myeloid - CML: Types of Treatment."
American Cancer Society. "Surgery for Chronic Myeloid Leukemia."
American Cancer Society. "Stem Cell Transplant for Chronic Myeloid Leukemia."
Leukemia & Lymphoma Society. "Stem Cell Transplant."
Cancer Research UK. "Bone marrow transplant."
University of Rochester Medical Center. "Chronic Myeloid Leukemia (CML): Stem Cell Transplant."
Leukemia & Lymphoma Society. "Clinical Trials."

Featured Content


What Are the Phases of Chronic Myeloid Leukemia?

Chronic myeloid leukemia is staged into three phases, chronic, accelerated, and blast phase. Learn what these terms mean.

Coping with the Mental Stress of CML

Why and how to make mental wellbeing a priority in your treatment for chronic myeloid leukemia.

5 Answers About Chronic Myeloid Leukemia

Roughly 15 percent of leukemias are chronic myeloid leukemia. Learn about CML phases, treatments, and how it differs from acute myeloid leukemia.

4 Tips for Staying Healthy With Chronic Phase CML

Here are a few basic tips for staying healthy and managing chronic myeloid leukemia.

How Chronic Myeloid Leukemia Affects the Body

Learn how CML disrupts the normal production of blood cells and the ways this can impact the body.